Market LIVE
Published markets; coverage varies by country
Product profile · United States

RYTELO

 ·  Patent Litigation & Settlement History ↓

IngredientIMETELSTAT SODIUM
Application typeNDA
Application217779
Product001
Dosage formPOWDER
RouteINTRAVENOUS
StrengthEQ 47MG BASE/VIAL
Approval date2024-06-06
Marketing statusPrescription
Status event—
ApplicantGERON
Product source

Current GenericRadar decision

Year2033
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2033-03-15
Patent anchor2033-03-15
Exclusivity anchor2031-06-06
Protection date2039-06-16
First Final ANDA—
Status event—

ANCHOR_WITH_TAIL; US:NDA:217779:001; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
93884152026-09-09U U-3956NYU
| B1C03 issued-claim review2026-10-15: U
———
93884152026-09-09ORANGE_BOOK U-3956NYU
English description not available.
———
93884162026-09-09U U-3956NYU
| B1C03 issued-claim review2026-10-15: U
———
93884162026-09-09ORANGE_BOOK U-3956NYU
English description not available.
———
74949822026-12-27DS/DP —YNTRUE_DS
| B1C03 issued-claim review2026-10-15: TRUE_DS
———
74949822026-12-27ORANGE_BOOK —YNTRUE_DS
English description not available.
———
124420002033-03-15U U-3956NYU
| B1C03 issued-claim review2026-10-15: U
———
124420002033-03-15ORANGE_BOOK U-3956NYU
English description not available.
———
93754852033-03-15U U-3956NYU
| B1C03 issued-claim review2026-10-15: U
———
93754852033-03-15ORANGE_BOOK U-3956NYU
English description not available.
———
121717782039-06-16U U-3956NNU
| B1C03 issued-claim review2026-10-15: U
———
121717782039-06-16ORANGE_BOOK U-3956NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
ODE-4822024-06-062031-06-06English description not available.YY2031-06-06—Source
ODE-4822024-06-062031-06-06English description not available.YY2031-06-06
ODE-482
Full coverage date: 2031-06-06
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (8)
TypeDateRoleBasisSource
PATENT2026-09-09HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-09-09HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2026-12-27HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2033-03-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-03-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2039-06-16FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2033-03-15CANONICAL_DECISIONANCHOR_WITH_TAIL; US:NDA:217779:001; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.